Evidence map›Paper›PMID 34660534›Full record

ArticleFrontiers in chemistry2021

Non-Targeted Analysis Using Gas Chromatography-Mass Spectrometry for Evaluation of Chemical Composition of E-Vapor Products.

Niti H Shah, Michael R Noe, Kimberly A Agnew-Heard, Yezdi B Pithawalla, William P Gardner, Saibal Chakraborty, Nicholas McCutcheon, Hannah Grisevich, Thomas J Hurst, Michael J Morton and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Artificial intelligence to investigate metabolomics data for precision medicine.Metabolomics : Official journal of the Metabolomic Society · 2026
    Review
  4. Article
  5. A literature review addressing midwakh and e-cigarette use in the Gulf region.The Journal of the Egyptian Public Health Association · 2023
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Niti H ShahCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Michael R NoeCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Kimberly A Agnew-HeardCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Yezdi B PithawallaCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
William P GardnerCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Saibal ChakrabortyCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Nicholas McCutcheonCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Hannah GrisevichCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Thomas J HurstCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Michael J MortonCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Matt S MelvinCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
John H Miller IvCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Altria (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Premarket Tobacco Product Applications (PMTA) guidance issued by the Food and Drug Administration for electronic nicotine delivery systems (ENDSs) recommends that in addition to reporting harmful and potentially harmful constituents (HPHCs), manufacturers should evaluate these products for other chemicals that could form during use and over time. Although e-vapor product aerosols are considerably less complex than mainstream smoke from cigarettes and heated tobacco product (HTP) aerosols, there are challenges with performing a comprehensive chemical characterization. Some of these challenges include the complexity of the e-liquid chemical compositions, the variety of flavors used, and the aerosol collection efficiency of volatile and semi-volatile compounds generated from aerosols. In this study, a non-targeted analysis method was developed using gas chromatography-mass spectrometry (GC-MS) that allows evaluation of volatile and semi-volatile compounds in e-liquids and aerosols of e-vapor products. The method employed an automated data analysis workflow using Agilent MassHunter Unknowns Analysis software for mass spectral deconvolution, peak detection, and library searching and reporting. The automated process ensured data integrity and consistency of compound identification with >99% of known compounds being identified using an in-house custom mass spectral library. The custom library was created to aid in compound identifications and includes over 1,100 unique mass spectral entries, of which 600 have been confirmed from reference standard comparisons. The method validation included accuracy, precision, repeatability, limit of detection (LOD), and selectivity. The validation also demonstrated that this semi-quantitative method provides estimated concentrations with an accuracy ranging between 0.5- and 2.0-fold as compared to the actual values. The LOD threshold of 0.7 ppm was established based on instrument sensitivity and accuracy of the compounds identified. To demonstrate the application of this method, we share results from the comprehensive chemical profile of e-liquids and aerosols collected from a marketed e-vapor product. Applying the data processing workflow developed here, 46 compounds were detected in the e-liquid formulation and 55 compounds in the aerosol sample. More than 50% of compounds reported have been confirmed with reference standards. The profiling approach described in this publication is applicable to evaluating volatile and semi-volatile compounds in e-vapor products.

Indexed as

aerosole-cigaretteselectronic vapor productse-liquidsENDSGC-MSnon-targeted analysissemi-quantitative analysis

Identifiers

PMID34660534
PMCPMC8511636
OpenAlexW3201668480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.